164 related articles for article (PubMed ID: 32724280)
1. CHARACTERISTICS AND PROGNOSIS OF TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A CROATIAN SINGLE INstitution RETROSPECTIVE COHORT STUDY.
Tečić Vuger A; Šeparović R; Vazdar L; Pavlović M; Lepetić P; Šitić S; Bajić Ž; Šarčević B; Vrbanec D
Acta Clin Croat; 2020 Mar; 59(1):97-108. PubMed ID: 32724280
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns, healthcare resource utilization and outcomes for early stage triple-negative breast cancer in Japan.
Sanno H; Taniguchi K; Yoshimoto Y; Saji S
Future Oncol; 2024 Apr; 20(13):833-849. PubMed ID: 38305038
[TBL] [Abstract][Full Text] [Related]
5. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
6. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and prognostic analysis of Triple-negative Breast Cancer: Single institute experience.
Maka VV; Pancha H; Shukla SN; Talati SS; Shah PM; Patel KM; Anand AS; Shah SA; Patel AA; Parikh S
Gulf J Oncolog; 2016 Jan; 1(20):38-44. PubMed ID: 27050178
[TBL] [Abstract][Full Text] [Related]
8. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
Polley MC; Leon-Ferre RA; Leung S; Cheng A; Gao D; Sinnwell J; Liu H; Hillman DW; Eyman-Casey A; Gilbert JA; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari K; Couch F; Carter JM; Visscher DW; Nielsen TO; Goetz MP
Breast Cancer Res Treat; 2021 Feb; 185(3):557-566. PubMed ID: 33389409
[TBL] [Abstract][Full Text] [Related]
9. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
10. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
11. Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.
Budakoglu B; Altundag K; Aksoy S; Kaplan MA; Ozdemir NY; Berk V; Ozkan M; Algin E; Kandemir N; Dogu GG; Harputluoglu H; Arslan UY; Coskun U; Isikdogan A; Oksuzoglu B
J BUON; 2014; 19(4):872-8. PubMed ID: 25536589
[TBL] [Abstract][Full Text] [Related]
12. Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features.
Derkaoui T; Bakkach J; Mansouri M; Loudiyi A; Fihri M; Alaoui FZ; Barakat A; El Yemlahi B; Bihri H; Nourouti NG; Mechita MB
BMC Womens Health; 2016 Oct; 16(1):68. PubMed ID: 27770782
[TBL] [Abstract][Full Text] [Related]
13. [Breast cancer with triple-negative phenotype in the Russian patient population. Clinical and morphologic features].
Zhukova LG
Vopr Onkol; 2015; 61(2):189-94. PubMed ID: 26087596
[TBL] [Abstract][Full Text] [Related]
14. Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
Deniz M; DeGregorio A; DeGregorio N; Bekes I; Widschwendter P; Schochter F; Ernst K; Scholz C; Bauer EC; Aivazova-Fuchs V; Weissenbacher T; Kost B; Jueckstock J; Andergassen U; Steidl J; Trapp E; Fasching PA; Häberle L; Beckmann MW; Schneeweiss A; Schrader I; Janni W; Rack B; Friedl TW
Breast; 2019 Apr; 44():81-89. PubMed ID: 30690254
[TBL] [Abstract][Full Text] [Related]
15. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in patients with small node-negative invasive breast cancer.
Bao J; Donovan C; Amersi F; Zhang X; Giuliano AE; Chung A
Breast J; 2019 Jul; 25(4):638-643. PubMed ID: 31079425
[TBL] [Abstract][Full Text] [Related]
18. Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.
Khalifa J; Duprez-Paumier R; Filleron T; Lacroix Triki M; Jouve E; Dalenc F; Massabeau C
Breast J; 2016 Sep; 22(5):510-9. PubMed ID: 27261365
[TBL] [Abstract][Full Text] [Related]
19. Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
Rayson D; Payne JI; Michael JCR; Tsuruda KM; Abdolell M; Barnes PJ
Clin Breast Cancer; 2018 Oct; 18(5):e955-e960. PubMed ID: 29885790
[TBL] [Abstract][Full Text] [Related]
20. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings.
Abdel-Fatah TM; Perry C; Dickinson P; Ball G; Moseley P; Madhusudan S; Ellis IO; Chan SY
Ann Oncol; 2013 Nov; 24(11):2801-7. PubMed ID: 23908177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
